Dr. Florian Montel grew in the southeast of France and obtained his Ph.D. at Sanofi-Aventis in 2005. After his post-doctoral position at Novartis, he spent 8 years at UCB in Belgium being project leader of diverse CNS projects, his work led to the finding of the first human PET tracer for the SV2A receptor. In 2014, he joined Boehringer Ingelheim as a project leader in the Medicinal Chemistry department in Biberach an der Riss, Germany. Since his inception, he is leading the opnMe.com team and as head of the Open Science group is overseeing the open innovation initiatives of the company from opnMe.com to the coordination of the Public-Private-Partnerships or the collaborations with the BioMed X institute. His motivation is to foster life science innovation by creating bridges between academic researchers and Boehringer Ingelheim.
Login or Register
You need to be logged in to use this feature.
Further Activities to have a look at